Search Results - David C. Montefiori

Refine Results
  1. 1
    Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates

    Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates by Barton F. Haynes, David C. Montefiori

    Published 2006
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Dose–response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies

    Dose–response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies by Nicholas E. Webb, David C. Montefiori, Benhur Lee

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Broadly neutralizing monoclonal antibodies for HIV prevention

    Broadly neutralizing monoclonal antibodies for HIV prevention by Maurine D. Miner, Lawrence Corey, David C. Montefiori

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.

    Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. by David C. Montefiori, William E. Robinson, William M. Mitchell

    Published 1988
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d

    Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d by Thomas D. Green, David C. Montefiori, Ted M. Ross

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Neutralization tiers of HIV-1

    Neutralization tiers of HIV-1 by David C. Montefiori, Mario Roederer, Lynn Morris, Michael S. Seaman

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay

    Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay by David C. Montefiori, William E. Robinson, Shirley S. Schuffman, William M. Mitchell

    Published 1988
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Insensitivity of Paediatric HIV-1 Subtype C Viruses to Broadly Neutralising Monoclonal Antibodies Raised against Subtype B

    Insensitivity of Paediatric HIV-1 Subtype C Viruses to Broadly Neutralising Monoclonal Antibodies Raised against Subtype B by Elin S. Gray, Tammy Meyers, Glenda Gray, David C. Montefiori, Lynn Morris

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection

    Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection by David C. Montefiori, Tanya S. Hill, Ha T. T. Vo, Bruce D. Walker, Eric Rosenberg

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1

    Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1 by Emily J. Platt, Miroslawa Bilska, Susan L. Kozak, David Kabat, David C. Montefiori

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions

    Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions by David C. Montefiori, Quentin J. Sattentau, Jorge Flores, José Esparza, John R. Mascola

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Vaccine protection by a triple deletion mutant of simian immunodeficiency virus

    Vaccine protection by a triple deletion mutant of simian immunodeficiency virus by Michael S. Wyand, Kelledy Manson, M Garcia-Moll, David C. Montefiori, Ronald C. Desrosiers

    Published 1996
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Rhesus Macaques That Become Systemically Infected With Pathogenic SHIV 89.6-PD After Intravenous, Rectal, or Vaginal Inoculation and Fail to Make an Antiviral Antibody Response Rapidly Develop AIDS

    Rhesus Macaques That Become Systemically Infected With Pathogenic SHIV 89.6-PD After Intravenous, Rectal, or Vaginal Inoculation and Fail to Make an Antiviral Antibody Response Rap... by Yichen Lu, C. David Pauza, Xusheng Lü, David C. Montefiori, Christopher J. Miller

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State

    The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State by Rachael A. Mansbach, Srirupa Chakraborty, Kien Nguyen, David C. Montefiori, Bette Korber, S. Gnanakaran

    Published 2020
    Get full text
    Pré-impressão
    Save to List
    Saved in:
  15. 15
    The SARS-CoV-2 Spike variant D614G favors an open conformational state

    The SARS-CoV-2 Spike variant D614G favors an open conformational state by Rachael A. Mansbach, Srirupa Chakraborty, Kien Nguyen, David C. Montefiori, Bette Korber, S. Gnanakaran

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection

    Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection by Peter Hraber, Michael S. Seaman, Robert T. Bailer, John R. Mascola, David C. Montefiori, Bette Korber

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Generation of Neutralizing Activity against Human Immunodeficiency Virus Type 1 in Serum by Antibody Gene Transfer

    Generation of Neutralizing Activity against Human Immunodeficiency Virus Type 1 in Serum by Antibody Gene Transfer by Anne D. Lewis, Ruju Chen, David C. Montefiori, Philip R. Johnson, K. Reed Clark

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Enhanced Avidity Maturation of Antibody to Human Immunodeficiency Virus Envelope: DNA Vaccination with gp120–C3d Fusion Proteins

    Enhanced Avidity Maturation of Antibody to Human Immunodeficiency Virus Envelope: DNA Vaccination with gp120–C3d Fusion Proteins by Ted M. Ross, Yan Xu, Thomas D. Green, David C. Montefiori, Harriet L. Robinson

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41

    Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41 by Lautaro G. Perez, Matthew R. Costa, Christopher A. Todd, Barton F. Haynes, David C. Montefiori

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques

    Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques by David C. Montefiori, William E. Robinson, Vanessa M. Hirsch, Ann Modliszewski, W M Mitchell, Paul Johnson

    Published 1990
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: